{"preliminary_commentary":{"by_channel":{"x_thread":4},"note":"Preliminary. Indexed podcasts, YouTube videos and X posts that name this trial so far. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this."},"free_build":{"available":false},"commentary_summary":null,"name":"EMBOLD SCLC-301","nct_id":"NCT07099898","offer":{"currency":"USD","how":"Order at https://www.erudio.com/contact?report=embold-sclc-301-nct07099898. The price is an estimate of verified statements from the commentary indexed so far, fixed at order. Final coverage is set when the report is built. We build the report within 24 hours of confirming the order and deliver it when it passes our checks; if it cannot be built to our standard, nothing is charged.","price_usd":750,"size":"focused","size_rule":"Focused: 1–150 verified statements, estimated at 14 per indexed commentary source"},"registry":{"acronym":null,"arms":[{"description":null,"label":"Risvutatug rezetecan (Ris-Rez)","type":"EXPERIMENTAL"},{"description":null,"label":"Topotecan","type":"ACTIVE_COMPARATOR"}],"collaborators":[],"completion_date":{"date":"2029-09-28","type":"ESTIMATED"},"conditions":["Neoplasms, Lung"],"enrollment":{"count":420,"type":"ESTIMATED"},"has_results":false,"interventions":[{"name":"Risvutatug rezetecan (Ris-Rez)","otherNames":[],"type":"BIOLOGICAL"},{"name":"Topotecan","otherNames":[],"type":"DRUG"}],"last_update":"2026-10-20","lead_sponsor":"GlaxoSmithKline","official_title":"Phase 3, Multicenter, Randomized, Open-label Clinical Study of GSK5764227, a B7-H3 Antibody Drug Conjugate (ADC), Compared With Topotecan in Participants With Relapsed Small Cell Lung Cancer (SCLC)","overall_status":"RECRUITING","phases":["PHASE3"],"primary_completion_date":{"date":"2027-11-05","type":"ESTIMATED"},"primary_outcomes":[{"measure":"Overall Survival (OS)","timeFrame":"Up to approximately 113 weeks"}],"references":[],"start_date":{"date":"2025-08-11","type":"ACTUAL"},"study_type":"INTERVENTIONAL","title":"A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) [EMBOLD SCLC-301]","url":"https://clinicaltrials.gov/study/NCT07099898"},"report":null,"schema_id":"erudio.trial_listing","schema_version":"3.0","state":"listed","state_text":"No report yet. It can be ordered.","url":"https://www.erudio.com/trials/embold-sclc-301-nct07099898"}